Literature DB >> 4230117

The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage.

V J Marder, N R Shulman, W R Carroll.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4230117

Source DB:  PubMed          Journal:  Trans Assoc Am Physicians        ISSN： 0066-9458


× No keyword cloud information.
  6 in total

1.  Quantitation of fragment X formation during thrombolytic therapy with streptokinase and tissue plasminogen activator.

Authors:  J Owen; K D Friedman; B A Grossman; C Wilkins; A D Berke; E R Powers
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

2.  The antigenic determinant of fibrin(ogen) measured with agglutination inhibition immunoassays.

Authors:  A Molla; M B Donati; J Vermylen
Journal:  J Clin Pathol       Date:  1974-06       Impact factor: 3.411

3.  Discriminating neoantigenic differences between fibrinogen and fibrin derivatives.

Authors:  E F Plow; T S Edgington
Journal:  Proc Natl Acad Sci U S A       Date:  1973-04       Impact factor: 11.205

4.  Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo.

Authors:  E Plow; T S Edgington
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

5.  Babesia bovis (argentina): analysis of fibrinogen-like proteins during infection.

Authors:  B V Goodger; I G Wright
Journal:  Z Parasitenkd       Date:  1979-12-01

6.  Plasmic degradation of crosslinked fibrin. Characterization of new macromolecular soluble complexes and a model of their structure.

Authors:  C W Francis; V J Marder; G H Barlow
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.